Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Treasury Shares (2020 - 2025)

Agilon Health's Treasury Shares history spans 5 years, with the latest figure at $16.2 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 139.1% year-over-year to $16.2 million; the TTM value through Dec 2025 reached $16.2 million, up 139.1%, while the annual FY2025 figure was $16.2 million, 139.1% up from the prior year.
  • Treasury Shares reached $16.2 million in Q4 2025 per AGL's latest filing, up from $6.8 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $16.2 million in Q4 2025 to a low of $1.8 million in Q4 2022.
  • Average Treasury Shares over 4 years is $8.9 million, with a median of $9.6 million recorded in 2023.
  • Peak YoY movement for Treasury Shares: skyrocketed 426.89% in 2023, then decreased 29.31% in 2024.
  • A 4-year view of Treasury Shares shows it stood at $1.8 million in 2022, then surged by 426.89% to $9.6 million in 2023, then dropped by 29.31% to $6.8 million in 2024, then soared by 139.1% to $16.2 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Treasury Shares are $16.2 million (Q4 2025), $6.8 million (Q4 2024), and $9.6 million (Q4 2023).